Dina Jacobs, M.D.
Professor of Neurology at the Hospital of the University of Pennsylvania
Clinical Director, Penn MS and Related Disorders Program , Perelman School of Medicine at the Hospital of the University of Pennsylvania
Director, Community Outreach and Network Development, Penn MS and Related Disorders Program , Perelman School of Medicine at the Hospital of the University of Pennsylvania
Neuroscience MS Disease Team Lead , Penn Medicine
Clinical Director, Center for Neuroinflammation and Neurotherapeutics, Penn Medicine
Neurology Clinical Outpatient Director, Penn Medicine
Neurology Outpatient Clinical Director, Practice Based Leadership Program, Penn Medicine
Co-Chief, Division of MS and Related Disorders, Penn Medicine
Department: Neurology
Contact information
Department of Neurology
Hospital of the University of Pennsylvania
3400 Spruce Street
3 West Gates Building
Philadelphia, PA 19104
Hospital of the University of Pennsylvania
3400 Spruce Street
3 West Gates Building
Philadelphia, PA 19104
Office: (215) 662-3647
Fax: (215) 349-5579
Fax: (215) 349-5579
Education
B.A. (Natural Science, Spanish)
University of Pennsylvania , 1990.
M.D.
University of Pennsylvania, 1996.
B.A. (Natural Science, Spanish)
University of Pennsylvania , 1990.
M.D.
University of Pennsylvania, 1996.
Post-Graduate Training
Intern, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, 1996-1997.
Resident, Department of Neurology, Hospital of the University of Pennsylvania, Philadelphia, 1997-2000.
Clinical Instructor, Divisions of Multiple Sclerosis and Neuro-Ophthalmology, Hospital of the University of Pennsylvania, Philadelphia, 2000-2002.
Fellow, Multiple Sclerosis, Hospital of the University of Pennsylvania, Philadelphia , 2000-2001.
Fellow, Neuro-Ophthalmology , Hospital of the University of Pennsylvania, Scheie Eye Institute, Philadelphia, 2001-2002.
Intern, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, 1996-1997.
Resident, Department of Neurology, Hospital of the University of Pennsylvania, Philadelphia, 1997-2000.
Clinical Instructor, Divisions of Multiple Sclerosis and Neuro-Ophthalmology, Hospital of the University of Pennsylvania, Philadelphia, 2000-2002.
Fellow, Multiple Sclerosis, Hospital of the University of Pennsylvania, Philadelphia , 2000-2001.
Fellow, Neuro-Ophthalmology , Hospital of the University of Pennsylvania, Scheie Eye Institute, Philadelphia, 2001-2002.
Certifications
American Board of Psychiatry and Neurology , 2001.
American Board of Psychiatry and Neurology; Recertification, 2011.
American Board of Psychiatry and Neurology; Recertification, 2022.
Permanent linkAmerican Board of Psychiatry and Neurology , 2001.
American Board of Psychiatry and Neurology; Recertification, 2011.
American Board of Psychiatry and Neurology; Recertification, 2022.
Selected Publications
Baldin E, De Santis C , Bove R, Jacobs D, McDonell J, Rijke N, Saylor D, Viswanathan S, Nonino F, and the KNOWwMS working group: Knowledge Gaps in Reproductive Health among Women with MS: an international survey. European Academy of Neurology Congress, Geneva, Switzerland 2026.Aggarwal A, Kavanaugh L, Santos I, Gilliard S, Wilson E, Giardino M, Jefferson A, Elahi A, Passarella M, Honeywell S, Gitelman Y, Lee K, Jacobs D : A novel approach for operationalizing imaging import from external institutions American Academy of Neurology Annual Meeting, Chicago, IL 2026.
Cooper EC, Bakhtiar N, Bar-Or A, Brandstadter RB, Gur RC, Horwath EA, Jacobs DA, Perrone CM, Roalf DR, Ruparel K, Satterthwaite TD, Shinohara RT, Schindler MK, Baller EB : Penn Computerized Neurocognitive Battery Reveals Global and Task-Specific Deficits Across Multiple Cognitive Domains in Multiple Sclerosis ACTRIMS Annual Meeting, San Diego, CA 2026.
Virupakshaia A, Gill AJ, Schoeps VA, Wilson EA, Wilson JA, Do D, Bar-Or A, Jacobs DA*, Berger JR* *Co-Senior Authors: The Effect of Ocrelizumab on Anti‐JC Virus Antibody Index. Brain and Behavior 2026.
Pfister A, Desai N, Lane C, Sweeney Smith M, Sekella N, Zimmerman V, Jacobs D: Virtual Dance Program for Multiple Sclerosis: Feasibility, Quality of Life, and Motor Imagery Outcomes. International Journal of MS Care July 2025.
Saylor D, Rijke N, McDonell J, Laurson-Doube J, Avasarala J, Baldin E, Banerjee TK, Bogdanovic I, Bove R, Chawla DK, Costello K, Del Giovane C, Abkari NE, Filippini G, Foschi M, Gonzalez-Lorenzo M, Helme A, Jacobs D, Kalincik T, Mantel-Teeuwisse A, Minozzi S, Navas C, Nonino F, Ojo OO, Ozcan B, Pasi E, Peryer G, Prato Chichiraldi A, Ridley B, Sokhi DS, Traboulsee A, Tramacere I, Tye JS, Vecchi S, Viswanathan S, Xie F, Zeineddine M, Schunemann H, Piggott T. : Recommendations for essential medicines for multiple sclerosis in low-resource settings. Mult Scler 2025.
Hellwig K, Bove R, Oreja-Guevara C, Dobson R, Maillart E, Jacobs D, McElrath T, Derfuss TJ, Pietrasanta C,9, Kletzl H, Kazlauskaite A, Zecevic D,1 Raposo C, Lin C, Pasquarelli N, Vukusic S : Infant B-Cell Levels, Ocrelizumab Placental Transfer and Maternal Humoral Responses During Pregnancy: Primary Analysis of the Prospective, Multicenter, Open-Label Phase IV MINORE Study. ACTRIMS Annual Meeting, West Palm Beach, FL 2025.
Bove R, Oreja-Guevara C, Vukusic S, Shah A,4 Graham EL, McElrath T, Pietrasanta C, Dobson R, Maillart E, Jacobs D, Kletzl H, Kazlauskaite A, Zecevic D, Raposo C, Craveiro L, Lin C, Pasquarelli N, Hellwig K: Placental and Breastmilk Transfer of Ocrelizumab from Women with Multiple Sclerosis to Infants and Potential Impact on B-Cell Levels in the Phase IV MINORE and SOPRANINO Trials. Consortium of MS Centers Annual Meeting, Phoenix, AZ 2025.
Sekella N, Gilmore H, French E, Zimmerman V, Jacobs D, Narula S. : Developing and Piloting a Dedicated Support Group for Young Adults With Multiple Sclerosis. Int J MS Care 2025.
Cooper EC, Schindler MK, Bar-Or A, Brandstadter RB, Calkins ME, Gur R, Jacobs DA, Markowitz C, Moore T, Naydovich LR, Perrone CM, Ruparel K, Spangler BC, Troyan S, Shinohara RT, Satterthwaite TD, Baller EB.: Investigating mood and cognition in people with multiple sclerosis: a prospective cross-sectional study protocol. BMJ Open 2025.